Bio

Chadwick Mills is co-chair of Cooley's public companies practice, and specializes in corporate and securities law, and regularly acts as outside corporate counsel to public life sciences companies. Chad provides ongoing compliance and strategic advice to biotechnology, pharmaceutical and device companies and their boards of directors on a wide range of securities, corporate and investor outreach matters, including financial reporting and disclosure issues, shareholder engagement and activism, securities offerings and corporate governance matters, in each case based on his extensive experience in the public life sciences space. Chad has worked with or served as primary outside counsel to numerous current and former public life sciences clients, including: AcelRx Pharmaceuticals, BioMarin Pharmaceutical, Cerus Corporation, Conor Medsystems, Exelixis, Geron Corporation, GTx, Jazz Pharmaceuticals, Kosan Biosciences, Medivation, Molecular Devices, Rigel Pharmaceuticals, Seattle Genetics and Threshold Pharmaceuticals.